Bone marrow is a rich source of both adult stem and progenitor cells. Marrow-derived stem cells have been utilized extensively for over 40 years in the field of bone marrow transplantation, primarily for the treatment of a wide array of cancers and hematologic diseases for which over 60,000 transplants are performed each year. Orthopedic procedures, such as spinal fusions and the treatment of non-union fractures, also commonly utilize the patient’s own bone marrow. More recently, marrow-derived cells are showing promise in the treatment of a widening array of diseases and conditions.

StemCor’s devices and accompanying technology will harvest bone marrow from a donor in a rapid (<30 min), inexpensive outpatient procedure, under local anesthesia, by a single physician and with minimal training.

The proprietary MarrowMiner® System is designed to rapidly and easily harvest bone marrow in a minimally-invasive manner, in the outpatient setting, and without general anesthesia. This is in contrast to the current practice of bone marrow aspiration through the insertion of a needle into multiple sites in the iliac crest of the hip, which usually requires general anesthesia, an operating room, and multiple clinical personnel. Preclinical studies have demonstrated the ability of the MarrowMiner to safely harvest large volumes of marrow with significantly higher stem cell activity than is contained in standard needle aspirates.

Click on the titles to the left for more information about StemCor's products.